Matches in SemOpenAlex for { <https://semopenalex.org/work/W3204170658> ?p ?o ?g. }
- W3204170658 endingPage "204062072110324" @default.
- W3204170658 startingPage "204062072110324" @default.
- W3204170658 abstract "Background: Inhibitor development is the most serious treatment-related complication of replacement coagulation factor VIII (FVIII) therapy for patients with haemophilia A. Immune tolerance induction (ITI), which involves intensive and prolonged treatment with plasma-derived or recombinant FVIII, is the only clinically proven strategy for eradication of inhibitors. The bispecific antibody emicizumab is approved for use in patients with and without inhibitors to prevent bleeding but does not eliminate inhibitors. MOTIVATE ( www.motivate-study.com ) aims to capture different approaches to the treatment and management of patients with haemophilia A and inhibitors, document current ITI approaches from real-world clinical experience, and evaluate the efficacy and safety of ITI, emicizumab prophylaxis and ITI with emicizumab prophylaxis. Methods: The investigator-initiated MOTIVATE study [ClinicalTrials.gov identifier: NCT04023019; EudraCT 2019-003427-38] will investigate in real-life clinical practice the management of patients with haemophilia A of any severity who have developed inhibitors to FVIII. All treatment is at the investigator’s discretion. The following treatment approaches will be evaluated: Group 1 – ITI with Nuwiq ® , octanate ® or wilate ® and aPCC/rFVIIa if needed to treat bleeding episodes (BEs) or during surgery or for prophylaxis; Group 2 – ITI with Nuwiq ® , octanate ® or wilate ® and emicizumab prophylaxis and aPCC/rFVIIa if needed to treat BEs or during surgery; Group 3 – routine prophylaxis with emicizumab, aPCC or rFVIIa without ITI and aPCC/rFVIIa if needed to treat BEs or during surgery. Patients will not be randomised to a treatment group and may change groups during the study. Conclusions: It is planned to enrol 120 patients who will be followed for up to 5 years. Optional sub-studies will explore factors that may influence ITI results as well as the impact of different treatment approaches on important aspects of patient health, including joint and bone health and the risk of thrombotic events." @default.
- W3204170658 created "2021-10-11" @default.
- W3204170658 creator A5001869490 @default.
- W3204170658 creator A5076531502 @default.
- W3204170658 date "2021-01-01" @default.
- W3204170658 modified "2023-10-14" @default.
- W3204170658 title "Design of an international investigator-initiated study on MOdern Treatment of Inhibitor-positiVe pATiEnts with haemophilia A (MOTIVATE)" @default.
- W3204170658 cites W1821030915 @default.
- W3204170658 cites W2011766387 @default.
- W3204170658 cites W2052495499 @default.
- W3204170658 cites W2064386996 @default.
- W3204170658 cites W2072864431 @default.
- W3204170658 cites W2076953709 @default.
- W3204170658 cites W2086294372 @default.
- W3204170658 cites W2094975391 @default.
- W3204170658 cites W2100940425 @default.
- W3204170658 cites W2103667265 @default.
- W3204170658 cites W2117767595 @default.
- W3204170658 cites W2125606569 @default.
- W3204170658 cites W2136090954 @default.
- W3204170658 cites W2145213708 @default.
- W3204170658 cites W2148879334 @default.
- W3204170658 cites W2167801052 @default.
- W3204170658 cites W2323135022 @default.
- W3204170658 cites W2415139732 @default.
- W3204170658 cites W2515121250 @default.
- W3204170658 cites W2606150472 @default.
- W3204170658 cites W2626664330 @default.
- W3204170658 cites W2734287351 @default.
- W3204170658 cites W2761634319 @default.
- W3204170658 cites W2804605907 @default.
- W3204170658 cites W2804768912 @default.
- W3204170658 cites W2805799263 @default.
- W3204170658 cites W2888236874 @default.
- W3204170658 cites W2894977023 @default.
- W3204170658 cites W2895640185 @default.
- W3204170658 cites W2900118404 @default.
- W3204170658 cites W2901197207 @default.
- W3204170658 cites W2912013106 @default.
- W3204170658 cites W2918847366 @default.
- W3204170658 cites W2943226571 @default.
- W3204170658 cites W2953117569 @default.
- W3204170658 cites W2955601811 @default.
- W3204170658 cites W2965671309 @default.
- W3204170658 cites W2966381410 @default.
- W3204170658 cites W2986053761 @default.
- W3204170658 cites W2997756059 @default.
- W3204170658 cites W3015258942 @default.
- W3204170658 cites W3029999028 @default.
- W3204170658 cites W3047046471 @default.
- W3204170658 cites W3118996547 @default.
- W3204170658 cites W3125119901 @default.
- W3204170658 doi "https://doi.org/10.1177/20406207211032452" @default.
- W3204170658 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8474305" @default.
- W3204170658 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34589194" @default.
- W3204170658 hasPublicationYear "2021" @default.
- W3204170658 type Work @default.
- W3204170658 sameAs 3204170658 @default.
- W3204170658 citedByCount "6" @default.
- W3204170658 countsByYear W32041706582022 @default.
- W3204170658 countsByYear W32041706582023 @default.
- W3204170658 crossrefType "journal-article" @default.
- W3204170658 hasAuthorship W3204170658A5001869490 @default.
- W3204170658 hasAuthorship W3204170658A5076531502 @default.
- W3204170658 hasBestOaLocation W32041706581 @default.
- W3204170658 hasConcept C141071460 @default.
- W3204170658 hasConcept C177713679 @default.
- W3204170658 hasConcept C2777232031 @default.
- W3204170658 hasConcept C2777902738 @default.
- W3204170658 hasConcept C2778385053 @default.
- W3204170658 hasConcept C2779076696 @default.
- W3204170658 hasConcept C2908647359 @default.
- W3204170658 hasConcept C2986817661 @default.
- W3204170658 hasConcept C71924100 @default.
- W3204170658 hasConcept C99454951 @default.
- W3204170658 hasConceptScore W3204170658C141071460 @default.
- W3204170658 hasConceptScore W3204170658C177713679 @default.
- W3204170658 hasConceptScore W3204170658C2777232031 @default.
- W3204170658 hasConceptScore W3204170658C2777902738 @default.
- W3204170658 hasConceptScore W3204170658C2778385053 @default.
- W3204170658 hasConceptScore W3204170658C2779076696 @default.
- W3204170658 hasConceptScore W3204170658C2908647359 @default.
- W3204170658 hasConceptScore W3204170658C2986817661 @default.
- W3204170658 hasConceptScore W3204170658C71924100 @default.
- W3204170658 hasConceptScore W3204170658C99454951 @default.
- W3204170658 hasFunder F4320329500 @default.
- W3204170658 hasLocation W32041706581 @default.
- W3204170658 hasLocation W32041706582 @default.
- W3204170658 hasLocation W32041706583 @default.
- W3204170658 hasLocation W32041706584 @default.
- W3204170658 hasLocation W32041706585 @default.
- W3204170658 hasOpenAccess W3204170658 @default.
- W3204170658 hasPrimaryLocation W32041706581 @default.
- W3204170658 hasRelatedWork W1491311205 @default.
- W3204170658 hasRelatedWork W1993159801 @default.
- W3204170658 hasRelatedWork W2001205289 @default.
- W3204170658 hasRelatedWork W2084190998 @default.
- W3204170658 hasRelatedWork W2088492288 @default.